Skip to main content

Table 2 Final diagnostic distribution after the 18 months follow up period.

From: Plasmatic level of neurosin predicts outcome of mild cognitive impairment

 

>5.25

≤ 5.25

P (χ2 test)

MCI

12 (40%)

18 (60%)

0.437

AD

7 (30%)

16 (70%)

0.004

DVasc.Comp

12 (93%)

1 (7%)

<0.001

  1. Patients initially diagnosed with MCI were followed up for 18 months. Data show final diagnostic distribution in relation to their initial plasmatic levels of neurosin (≤ or > 5.25 ng/ml) and the association (p) value.